135 related articles for article (PubMed ID: 16020417)
1. The health effects of diethylstilbestrol revisited.
Lauver D; Nelles KK; Hanson K
J Obstet Gynecol Neonatal Nurs; 2005; 34(4):494-9. PubMed ID: 16020417
[TBL] [Abstract][Full Text] [Related]
2. Australia recognises cancer risk for "DES daughters".
Fickling D
Lancet; 2004 Jun; 363(9426):2059. PubMed ID: 15209080
[No Abstract] [Full Text] [Related]
3. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.
Hammes B; Laitman CJ
J Midwifery Womens Health; 2003; 48(1):19-29. PubMed ID: 12589302
[TBL] [Abstract][Full Text] [Related]
4. Clear cell adenocarcinoma associated with diethylstilbestrol: "overripeness ovopathy" as a risk or causal factor?
Jongbloet PH; Hanselaar AG; Bernheim JL
Am J Obstet Gynecol; 1995 May; 172(5):1651-2. PubMed ID: 7755098
[No Abstract] [Full Text] [Related]
5. The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy.
Troisi R; Hatch EE; Titus L
Pediatrics; 2016 Nov; 138(Suppl 1):S42-S44. PubMed ID: 27940976
[No Abstract] [Full Text] [Related]
6. Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guidelines.
Tedeschi CA; Rubin M; Krumholz BA
J Low Genit Tract Dis; 2005 Jan; 9(1):11-8. PubMed ID: 15870516
[TBL] [Abstract][Full Text] [Related]
7. Diethylstilbestrol and adenocarcinoma of the vagina.
Herbst AL
Am J Obstet Gynecol; 1999 Dec; 181(6):1576-8; discussion 1579. PubMed ID: 10601947
[No Abstract] [Full Text] [Related]
8. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
[TBL] [Abstract][Full Text] [Related]
10. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
11. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.
Huo D; Anderson D; Herbst AL
N Engl J Med; 2018 May; 378(18):1746-1748. PubMed ID: 29719188
[No Abstract] [Full Text] [Related]
13. DES exposure: an update.
Mittendorf R; Herbst AL
Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281
[TBL] [Abstract][Full Text] [Related]
14. The incidence of cervical and vaginal dysplasia after exposure to DES.
Richart RM
JAMA; 1986 Jan; 255(1):36-7. PubMed ID: 2999457
[No Abstract] [Full Text] [Related]
15. Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia.
Robboy SJ; Truslow GY; Anton J; Richart RM
Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S98-110. PubMed ID: 7030882
[TBL] [Abstract][Full Text] [Related]
16. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
17. [Diethylstilbestrol story].
Tournaire M; Epelboin S; Devouche E
Therapie; 2014; 69(1):101-14. PubMed ID: 24698194
[TBL] [Abstract][Full Text] [Related]
18. Diethylstilbestrol (DES) update. A message from the DESAD Project.
Powers D
Wis Med J; 1985 Feb; 84(2):11-4. PubMed ID: 3984375
[No Abstract] [Full Text] [Related]
19. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.
Herbst AL; Ulfelder H; Poskanzer DC; Longo LD
Am J Obstet Gynecol; 1999 Dec; 181(6):1574-5. PubMed ID: 10601946
[No Abstract] [Full Text] [Related]
20. Diethylstilbestrol, clear cell adenocarcinoma, and striking discoveries in Norway.
Forsberg JG
Am J Med; 1988 Jan; 84(1):184. PubMed ID: 3337129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
